ClinicalTrials.Veeva

Menu

Stress Management Therapy for Meniere's Disease (SMT)

O

Osaka University

Status

Unknown

Conditions

Meniere's Disease
Stress

Treatments

Behavioral: Lifestyle

Study type

Interventional

Funder types

Other

Identifiers

NCT01099046
yk19700512

Details and patient eligibility

About

Attacks in Meniere's disease, characterized by vertigo and hearing loss, are well known to occur repeatedly under stressed environment. Hitherto, its pathology was revealed to be inner ear hydrops through human temporal bone studies in 1938. For the pathogenesis of inner ear hydrops resulting in Meniere's attacks, plasma vasopressin elevation due to stress and V2 receptor overexpression in the inner ear could be essential as a basis of this disease. In the present study, we'd like to find the effective and feasible way to reduce plasma vasopressin level in patients with Meniere's disease.

Full description

BACKGROUND:

For the pathogenesis of inner ear hydrops resulting in Meniere's attacks, plasma vasopressin elevation due to stress and V2 receptor overexpression in the inner ear could be essential as a basis of this disease. In the present study, we'd like to find the effective and feasible way to reduce plasma vasopressin level in patients with Meniere's disease.

METHODS:

We estimate to enroll 200 Meniere's patients to four study groups in a randomized controlled trial at Osaka University Hospital during this study period 2010-2015. Patients are diagnosed as Meniere's patients according to the 1995 AAO-HNS criteria. Group-I consists of 50 patients who receive just traditional oral intake medication including anti-diuretics. Group-II consists of 50 patients who receive both medication and water intake (at least 2.0 litters per day). Group-III consists of 50 patients who receive both medication and tympanic tubing (under local anesthesia). Group-IV consists of 50 patients who receive both medication and sleep well (regular sleep program under dark everynight). Additional factors to medication in each group are supposed to have influence on hypothalamus. We follow up all these patients at least 12 months and evaluate stress, psychological and dizziness conditions using a couple of questionnaires. We also examine changes in plasma vasopressin level of patients in each group.

ESTIMATED RESULTS:

Through this study, we can understand the most effective and feasible way to reduce plasma vasopressin level in patients with Meniere's disease. Much more Meniere's patients may be rescued without invasive surgery.

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed as Meniere's patients according to the 1995 AAO-HNS criteria are included into this study.

Exclusion criteria

  • Patients refused our prepared four kinds of treatments are excluded from this study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

200 participants in 4 patient groups

medication only
No Intervention group
Description:
medication = anti-diuretics
Treatment:
Behavioral: Lifestyle
medication + water intake
Active Comparator group
Description:
anti-diuretics + water intake (at least 2.0 litters per day)
Treatment:
Behavioral: Lifestyle
medication + tympanic tubing
Active Comparator group
Description:
anti-diuretics + tympanic tubing (under local anesthesia)
Treatment:
Behavioral: Lifestyle
medication + regular sleep
Active Comparator group
Description:
anti-diuretics + regular sleep (regular sleep program under dark everynight)
Treatment:
Behavioral: Lifestyle

Trial contacts and locations

1

Loading...

Central trial contact

Arata Horii, M.D.,Ph.D.; Tadashi Kitahara, M.D.,Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems